Top Markets
Coin of the day
Grand Brilliance Group Holdings Limited Grand Brilliance Group Holdings Limited

Grand Brilliance Group Holdings Limited

8372
Pozycja w akcjach #31002
Grand Brilliance Group Holdings Limited, an investment holding entity,... Grand Brilliance Group Holdings Limited, an investment holding entity, primarily operates by distributing medical equipment and related items across Hong Kong. Its extensive product portfolio encompasses various medical supplies, including disposables, specialized instruments, and advanced medical machinery. The company also undertakes the development of innovative healthcare products. Beyond product distribution, it delivers comprehensive medical device solutions such as in-depth market trend assessments, strategic sourcing, post-sale support, technical training, equipment rental, and stringent quality assurance. Additionally, the firm manages maintenance services and holds several registered trademarks. Its diverse client base spans both public and private healthcare facilities, independent clinics, charitable groups, academic institutions, and direct consumers. Established in 1997, the company is headquartered in Tsuen Wan, Hong Kong, and operates as a subsidiary of B&A Success Limited.
Cena akcji
$0.01842138
Ostatnia synchronizacja: 2026-08-13
Kapitalizacja rynkowa
$14.74M
Zmiana (1 dzień)
9.92%
Zmiana (1 rok)
23.11%
Kraj
HK
Handel Grand Brilliance Group Holdings Limited (8372)

Kategoria

Zyski dla Grand Brilliance Group Holdings Limited (8372)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Grand Brilliance Group Holdings Limited, obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Grand Brilliance Group Holdings Limited od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$6.46B -
US
- -
US
$2.17B -
US
- -
US
$358.16M -
AU